Most SSRI side effects do go away after you stop taking the medication, but the timeline varies widely depending on the specific side effect. Some issues like nausea and headaches resolve within days. Others, like changes in sleep patterns, take a few weeks. And a small number of effects, particularly sexual dysfunction and weight changes, can linger for months or longer in some people.
Understanding what to expect helps you tell the difference between normal adjustment and something that needs attention. Here’s what the evidence says about how different side effects resolve once you stop.
The First Two Weeks: Discontinuation Symptoms
The earliest symptoms you’ll notice after stopping aren’t lingering side effects at all. They’re discontinuation symptoms, your body’s reaction to the sudden absence of the drug. These typically start within two to four days of your last dose and usually last one to two weeks. The most common complaints include nausea, vomiting, cramps, diarrhea, loss of appetite, dizziness, and sensory disturbances often described as “electric shock” sensations (commonly called brain zaps).
These discontinuation symptoms are distinct from the side effects you experienced while taking the medication. They appear rapidly, tend to fluctuate day to day, and resolve on their own as your body readjusts. One reliable way to tell the difference: discontinuation symptoms disappear quickly if you take a dose of the antidepressant, while a return of depression takes weeks of treatment to improve. If symptoms last beyond a month and are getting worse rather than better, that pattern points more toward a relapse of depression than a withdrawal effect.
How quickly you clear the drug from your system matters. Sertraline, for example, has a half-life of 24 to 32 hours, meaning it takes a few days to mostly leave your body. But its active metabolite lingers for 56 to 120 hours. Fluoxetine has an even longer effective half-life of around 10 days, which is why discontinuation symptoms tend to be milder with that particular SSRI. The shorter the half-life, the more abruptly your brain chemistry shifts, and the more noticeable the withdrawal period.
How Sleep Patterns Recover
SSRIs suppress REM sleep, which is why many people on these medications report vivid dreams, poor sleep quality, or feeling unrested. The good news is that basic sleep quality tends to normalize quickly after stopping, typically within two to four days. The deeper changes to your sleep architecture take longer. In a study of healthy volunteers taking fluoxetine, the timing of REM sleep and certain markers of deep sleep remained altered for several days after stopping, gradually returning to normal as the drug cleared from the bloodstream.
Some people actually experience a REM rebound after stopping, where REM sleep temporarily increases beyond your baseline. This can cause unusually intense or vivid dreams for a short period. It’s not harmful, and it settles down on its own.
Sexual Side Effects: The Slower Recovery
Sexual dysfunction is one of the most common reasons people want to stop SSRIs, and for most people, desire, arousal, and the ability to orgasm do improve after stopping. But this recovery isn’t always immediate. In one study, 9% of healthy volunteers still reported more than mild sexual dysfunction four weeks after stopping paroxetine, with erectile and ejaculatory function scores not yet back to baseline. In a clinical study comparing patients who switched off an SSRI to a non-serotonergic medication, 55% still had sexual dysfunction six months later, compared to just 4% of those who had never taken an SSRI.
A small subset of people develop what’s now formally recognized as Post-SSRI Sexual Dysfunction (PSSD). This involves lasting changes in genital sensation, reduced sexual desire, erectile dysfunction, or diminished ability to orgasm that persist for three months or more after stopping. The exact prevalence is unknown because it hasn’t been well studied, but the condition has established diagnostic criteria requiring that the dysfunction wasn’t present before starting the medication and can’t be explained by another medical condition or substance. If your sexual function hasn’t meaningfully improved after a few months off the medication, PSSD is worth discussing with your doctor.
Weight Changes After Stopping
If you gained weight on an SSRI, you might assume it will come off once you stop. That’s a common expectation, but the evidence doesn’t clearly support it. One review in Molecular Psychiatry noted that “it is commonly stated that patients return to their previous weight after they stop taking antidepressants, but this assumption is not evidence based.”
Animal research has found something more concerning: subjects exposed to antidepressants and then taken off them gained more weight over the following months when eating a high-fat diet than subjects who were never on antidepressants. The researchers described antidepressant exposure as a potentially “covert, insidious and enduring risk factor for obesity” even after discontinuation. This doesn’t mean weight loss is impossible after stopping, but it suggests the metabolic effects may not simply reverse on their own. Active changes to diet and exercise are likely more important than just waiting for the medication to clear.
What Counts as “Too Long”
The general pattern is that most discontinuation symptoms peak in the first week and resolve by the second. Some researchers define anything lasting beyond six weeks as a persistent post-discontinuation syndrome, which warrants closer medical evaluation. In rare cases, certain symptoms (particularly brain zaps and sensory disturbances) have been reported to persist for up to a year.
The challenge is distinguishing between three different things that can look similar: withdrawal symptoms, a rebound effect where original symptoms temporarily return more intensely than before, and a genuine relapse of the condition the SSRI was treating. Timing is your best clue. Withdrawal starts within days, fluctuates, and fades. Rebound also appears early but involves familiar depression or anxiety symptoms at a heightened intensity. A true relapse tends to develop more gradually and worsen steadily over weeks.
Why Tapering Matters for Recovery
How you stop affects how you feel afterward. Clinical guidelines now recommend a gradual, hyperbolic tapering approach rather than stopping abruptly or making large dose reductions. Hyperbolic tapering means making progressively smaller reductions as you get to lower doses, because the relationship between dose and effect on your brain isn’t linear. Cutting from 100mg to 50mg is a much smaller change in brain activity than cutting from 50mg to zero.
People who taper gradually tend to have fewer and milder discontinuation symptoms, which means the post-stopping period feels less like an ordeal and more like a smooth transition. If you stopped abruptly and are experiencing significant symptoms, restarting at a low dose and then tapering down slowly is a recognized strategy that often helps.
A Realistic Timeline
Putting it all together, here’s roughly what to expect:
- Days 2 to 4: Discontinuation symptoms begin (nausea, dizziness, brain zaps, irritability).
- Week 1 to 2: Discontinuation symptoms peak and begin fading. Sleep quality starts normalizing.
- Weeks 2 to 4: Most physical side effects have resolved. Sleep architecture returns closer to baseline. Some people still notice brain zaps or emotional sensitivity.
- Months 1 to 3: Sexual function improves for most people. Emotional regulation stabilizes. Lingering symptoms at this point deserve medical attention.
- Beyond 3 months: Any persistent sexual dysfunction may meet criteria for PSSD. Weight changes may require active lifestyle intervention rather than passive waiting.
Your individual timeline depends on which SSRI you were taking, how long you were on it, your dose, how quickly you tapered, and your own biology. Longer use and higher doses generally mean a longer adjustment period, but even people on low doses for short periods can experience noticeable discontinuation effects.